furosemid "hameln" 10 mg/ml injektionsvæske, opløsning
hameln pharma gmbh - furosemid - injektionsvæske, opløsning - 10 mg/ml
xylocain 5% kutanopløsning
aspen pharma trading limited - lidocain - kutanopløsning - 5%
attentin 20 mg tabletter
medice arzneimittel pütter gmbh & co. kg - dexamfetaminsulfat - tabletter - 20 mg
attentin 20 mg tabletter
orifarm a/s - dexamfetaminsulfat - tabletter - 20 mg
attentin 5 mg tabletter
paranova danmark a/s - dexamfetaminsulfat - tabletter - 5 mg
adakveo
novartis europharm limited - crizanlizumab - anæmi, sickle cell - other hematological agents - adakveo is indicated for the prevention of recurrent vaso occlusive crises (vocs) in sickle cell disease patients aged 16 years and older. it can be given as an add on therapy to hydroxyurea/hydroxycarbamide (hu/hc) or as monotherapy in patients for whom hu/hc is inappropriate or inadequate.
nulojix
bristol-myers squibb pharma eeig - belatacept - graft rejection; kidney transplantation - immunosuppressiva - nulojix, in combination with corticosteroids and a mycophenolic acid (mpa), is indicated for prophylaxis of graft rejection in adult recipients of a renal transplant.
marplan 10 mg tabletter
medilink a/s - isocarboxazid - tabletter - 10 mg
plasmalyte infusionsvæske, opløsning
baxter a/s - kaliumchlorid, magnesiumchloridhexahydrat, natriumacetattrihydrat, natriumchlorid, natriumgluconat - infusionsvæske, opløsning
plasmalyte glucos 50 mg/ml infusionsvæske, opløsning
baxter a/s - glucosemonohydrat, kaliumchlorid, magnesiumchloridhexahydrat, natriumacetattrihydrat, natriumchlorid, natriumgluconat - infusionsvæske, opløsning - 50 mg/ml